Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 3Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neuroblastoma 2Melanoma 2Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Cyclophosphamide 21fludarabine phosphate 13Cyclosporine 11Antilymphocyte Serum 11Peripheral Blood Stem Cell Transplantation 10Methotrexate 10Busulfan 10Cytarabine 9Filgrastim 8Radiotherapy 7Dexamethasone 7Whole-Body Irradiation 6Mycophenolic Acid 6Methylprednisolone 6Melphalan 6Exercise 6fludarabine 5Vincristine 5Daunorubicin 5Cord Blood Stem Cell Transplantation 5pegaspargase 4Rituximab 4Palliative Care 4Mercaptopurine 4Etoposide 4Early Intervention, Educational 4Blood Specimen Collection 4Asparaginase 4Alemtuzumab 4Thioguanine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00665002 2015-02-27

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
16 enrolled 8 charts
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡